Kristin Lambrecht

Kristin Lambrecht, PA-C

Program Director, Cardiovascular Imaging Research Center and Core Lab

As the Program Director for the Cardiovascular Imaging Research Center and Core Lab, Kristin Lambrecht facilitates a multidisciplinary staff and physician team to advance research and education in cardiovascular imaging with the ultimate goal of improving patients’ lives through a world-class research center. Kristin also works closely with the Valve Science Center team, having previously led the valve team as their Program Director before refocusing with the imaging team.

Kristin is a graduate of the University of Minnesota with a degree in Physiology and Augsburg College’s Physician Assistant program. She came to MHIF from Medtronic where she amassed deep and strong experience in clinical research, therapy development, and evidence dissemination. At MHIF, she leverages these experiences as the Cardiovascular Imaging Research Valve Science Center team leads the way in transformative research and education for heart disease.

Back to Imaging Team Back to Valve Team

Kristin Lambrecht
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.